Emerald Mutual Fund Advisers Trust Madrigal Pharmaceuticals, Inc. Transaction History
Emerald Mutual Fund Advisers Trust
- $1.75 Billion
- Q3 2025
A detailed history of Emerald Mutual Fund Advisers Trust transactions in Madrigal Pharmaceuticals, Inc. stock. As of the latest transaction made, Emerald Mutual Fund Advisers Trust holds 35,091 shares of MDGL stock, worth $18.6 Million. This represents 0.92% of its overall portfolio holdings.
Number of Shares
35,091
Previous 36,920
4.95%
Holding current value
$18.6 Million
Previous $11.2 Million
44.04%
% of portfolio
0.92%
Previous 0.76%
Shares
10 transactions
Others Institutions Holding MDGL
# of Institutions
407Shares Held
23.1MCall Options Held
665KPut Options Held
514K-
Baker Bros. Advisors LP New York, NY2.14MShares$1.13 Billion8.0% of portfolio
-
Rtw Investments, LP New York, NY1.99MShares$1.06 Billion12.22% of portfolio
-
John Paulson Paulson & Co. Inc. | New York, Ny1.91MShares$1.01 Billion31.28% of portfolio
-
Janus Henderson Group PLC London, X01.84MShares$975 Million0.41% of portfolio
-
Avoro Capital Advisors LLC New York, NY1.83MShares$970 Million11.49% of portfolio
About MADRIGAL PHARMACEUTICALS, INC.
- Ticker MDGL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 17,103,400
- Market Cap $9.05B
- Description
- Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...